Publications

Found 58 results
Filters: Keyword is HIV-1  [Clear All Filters]
2013
Doores KJ, Huber M, Le KM, Wang S-K, Doyle-Cooper C, Cooper A, Pantophlet R, Wong C-H, Nemazee D, Burton DR.  2013.  2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.. J Virol. 87(4):2234-41.
Gavrilyuk J, Ban H, Uehara H, Sirk SJ, Saye-Francisco K, Cuevas A, Zablowsky E, Oza A, Seaman MS, Burton DR et al..  2013.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.. J Virol. 87(9):4985-93.
Shingai M, Nishimura Y, Klein F, Mouquet H, Donau OK, Plishka R, Buckler-White A, Seaman M, Piatak M, Lifson JD et al..  2013.  Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.. Nature. 503(7475):277-80.
Ringe RP, Sanders RW, Yasmeen A, Kim HJ, Lee J H, Cupo A, Korzun J, Derking R, van Montfort T, Julien J-P et al..  2013.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.. Proc Natl Acad Sci U S A. 110(45):18256-61.
Isik G, P Y Chung N, van Montfort T, Menis S, Matthews K, Schief WR, Moore JP, Sanders RW.  2013.  An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells.. PLoS One. 8(6):e67309.
Porichis F, Hart MG, Zupkosky J, Barblu L, Kaufmann DE.  2013.  In vitro assay to evaluate the impact of immunoregulatory pathways on HIV-specific CD4 T cell effector function.. J Vis Exp. (80):e50821.
Klasse P J, Depetris RS, Pejchal R, Julien J-P, Khayat R, Lee J H, Marozsan AJ, Cupo A, Cocco N, Korzun J et al..  2013.  Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein.. J Virol. 87(17):9873-85.
Zhou T, Zhu J, Wu X, Moquin S, Zhang B, Acharya P, Georgiev IS, Altae-Tran HR, Chuang G-Y, M Joyce G et al..  2013.  Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.. Immunity. 39(2):245-58.
Chuang G-Y, Acharya P, Schmidt SD, Yang Y, Louder MK, Zhou T, Kwon Y D, Pancera M, Bailer RT, Doria-Rose NA et al..  2013.  Residue-level prediction of HIV-1 antibody epitopes based on neutralization of diverse viral strains.. J Virol. 87(18):10047-58.
Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK.  2013.  Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design.. Immunity. 38(3):606-17.
2012
Ota T, Doyle-Cooper C, Cooper AB, Huber M, Falkowska E, Doores KJ, Hangartner L, Le K, Sok D, Jardine J et al..  2012.  Anti-HIV B Cell lines as candidate vaccine biosensors.. J Immunol. 189(10):4816-24.
Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E et al..  2012.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.. N Engl J Med. 367(5):399-410.
Feng Y, McKee K, Tran K, O'Dell S, Schmidt SD, Phogat A, Forsell MN, Karlsson Hedestam GB, Mascola JR, Wyatt RT.  2012.  Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.. J Biol Chem. 287(8):5673-86.
Feinberg MB, Ahmed R.  2012.  Born this way? Understanding the immunological basis of effective HIV control. Nat Immunol. 13(7):632-4.
Burton DR, Poignard P, Stanfield RL, Wilson IA.  2012.  Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses.. Science. 337(6091):183-6.
Kwon DS, Angin M, Hongo TC, Law KM, Johnson J, Porichis F, Hart MG, Pavlik DF, Tighe DP, Kavanagh DG et al..  2012.  CD4+ CD25+ regulatory T cells impair HIV-1-specific CD4 T cell responses by upregulating interleukin-10 production in monocytes.. J Virol. 86(12):6586-94.
Klatt NR, Silvestri G.  2012.  CD4+ T cells and HIV: A paradoxical Pas de Deux.. Sci Transl Med. 4(123):123ps4.
Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PNP, Spencer DIR, Seaman MS et al..  2012.  Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.. Proc Natl Acad Sci U S A. 109(47):E3268-77.

Pages